Hypha Discovery Signs Natural Products Drug Discovery Collaboration with Ferrer Grupo

30-Sep-2011 - United Kingdom

Hypha Discovery Ltd announced a collaboration with Ferrer Grupo to mine Hypha's MycoDiverse™ library to discover novel low molecular weight natural products to treat microbial infections.

Hypha’s CEO, Dr Liam Evans said “We recognise the challenges facing the discovery of novel antibiotics and firmly believe that pairing our technology with Ferrer’s experience and excellence in pharmaceutical R&D represents an ideal fit and we are pleased to be working in collaboration with scientists who recognise the potential of our technology and discovery resources.”

Ferrer’s R&D Director, Dr Antonio Guglietta, said “we are very excited about the collaboration with Hypha since we see a high degree of complementarity between Hypha’s’ expertise and skill in the field of natural products and ours in the discovery and development of new anti-microbial drugs. We expect this complementarity to be especially fruitful in the discovery of new niche antimicrobial cures, a therapeutic area to which Ferrer is highly committed”.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance